Literature DB >> 19426216

Yin-Yang of costimulation: crucial controls of immune tolerance and function.

Roza I Nurieva1, Xikui Liu, Chen Dong.   

Abstract

SUMMARY: In addition to signals from the T-cell receptor complex, it has been recognized for many years that a 'second' signal, most notably from CD28, is also important in T-cell activation. In the recent years, many new members of CD28 family as well as the molecules that share structural homology to CD28 ligands CD80 and CD86 have been discovered. Interestingly, some of these proteins function to dampen T-cell activation and regulate the induction of T-cell tolerance. Therefore, positive and negative costimulation are the two sides of the coin to fine tune T-cell receptor signaling to determine the outcome of T-cell receptor engagement-tolerance versus function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19426216      PMCID: PMC2875245          DOI: 10.1111/j.1600-065X.2009.00769.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  127 in total

1.  Characterization of B7S3 as a novel negative regulator of T cells.

Authors:  Yang Yang; Xikui K Liu; Thang Nguyen; Caroline Bishop; Daniel Graf; Chen Dong
Journal:  J Immunol       Date:  2007-03-15       Impact factor: 5.422

2.  BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation.

Authors:  Heather A Arnett; Sabine S Escobar; Eva Gonzalez-Suarez; Alison L Budelsky; Lori A Steffen; Norman Boiani; Ming Zhang; Gerald Siu; Avery W Brewer; Joanne L Viney
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

3.  B7-H3 regulates the development of experimental allergic conjunctivitis in mice.

Authors:  Atsuki Fukushima; Tamaki Sumi; Ken Fukuda; Naoki Kumagai; Teruo Nishida; Tomohide Yamazaki; Hisaya Akiba; Ko Okumura; Hideo Yagita; Hisayuki Ueno
Journal:  Immunol Lett       Date:  2007-08-23       Impact factor: 3.685

4.  Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.

Authors:  Deborah A Young; Martin Hegen; Hak Ling Margery Ma; Matthew J Whitters; Leo M Albert; Leslie Lowe; Mayra Senices; Paul W Wu; Barbara Sibley; Yelena Leathurby; Tom P Brown; Cheryl Nickerson-Nutter; James C Keith; Mary Collins
Journal:  Arthritis Rheum       Date:  2007-04

5.  Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA.

Authors:  Di Yu; Andy Hee-Meng Tan; Xin Hu; Vicki Athanasopoulos; Nicholas Simpson; Diego G Silva; Andreas Hutloff; Keith M Giles; Peter J Leedman; Kong Peng Lam; Christopher C Goodnow; Carola G Vinuesa
Journal:  Nature       Date:  2007-11-08       Impact factor: 49.962

6.  A costimulation-initiated signaling pathway regulates NFATc1 transcription in T lymphocytes.

Authors:  Roza I Nurieva; Sergei Chuvpilo; Eric D Wieder; Keith B Elkon; Richard Locksley; Edgar Serfling; Chen Dong
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

7.  Essential autocrine regulation by IL-21 in the generation of inflammatory T cells.

Authors:  Roza Nurieva; Xuexian O Yang; Gustavo Martinez; Yongliang Zhang; Athanasia D Panopoulos; Li Ma; Kimberly Schluns; Qiang Tian; Stephanie S Watowich; Anton M Jetten; Chen Dong
Journal:  Nature       Date:  2007-06-20       Impact factor: 49.962

8.  IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells.

Authors:  Thomas Korn; Estelle Bettelli; Wenda Gao; Amit Awasthi; Anneli Jäger; Terry B Strom; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nature       Date:  2007-06-20       Impact factor: 49.962

9.  IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways.

Authors:  Liang Zhou; Ivaylo I Ivanov; Rosanne Spolski; Roy Min; Kevin Shenderov; Takeshi Egawa; David E Levy; Warren J Leonard; Dan R Littman
Journal:  Nat Immunol       Date:  2007-06-20       Impact factor: 25.606

10.  B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome.

Authors:  Xingxing Zang; R Houston Thompson; Hikmat A Al-Ahmadie; Angel M Serio; Victor E Reuter; James A Eastham; Peter T Scardino; Padmanee Sharma; James P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-27       Impact factor: 11.205

View more
  54 in total

1.  Antigen-induced regulation of T-cell motility, interaction with antigen-presenting cells and activation through endogenous thrombospondin-1 and its receptors.

Authors:  Sten-Erik Bergström; Mehmet Uzunel; Toomas Talme; Eva Bergdahl; Karl-Gösta Sundqvist
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

Review 2.  T-cell activation and transplantation tolerance.

Authors:  Bhavana Priyadharshini; Dale L Greiner; Michael A Brehm
Journal:  Transplant Rev (Orlando)       Date:  2011-11-08       Impact factor: 3.943

Review 3.  Overview of the immune response.

Authors:  David D Chaplin
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

4.  Anti-CD3 mAb treatment cures PDL1-/-.NOD mice of diabetes but precipitates fatal myocarditis.

Authors:  Bechara Mfarrej; Mary Keir; Shirine Dada; Subbulaxmi Trikudanathan; Mohamed H Sayegh; Arlene H Sharpe; Indira Guleria
Journal:  Clin Immunol       Date:  2011-03-24       Impact factor: 3.969

5.  BIN1 reverses PD-L1-mediated immune escape by inactivating the c-MYC and EGFR/MAPK signaling pathways in non-small cell lung cancer.

Authors:  J Wang; Y Jia; S Zhao; X Zhang; X Wang; X Han; Y Wang; M Ma; J Shi; L Liu
Journal:  Oncogene       Date:  2017-07-17       Impact factor: 9.867

Review 6.  Immune checkpoint inhibitors in melanoma.

Authors:  Adam J Cooper; Matteo S Carlino; Richard F Kefford
Journal:  Melanoma Manag       Date:  2015-08-10

7.  Agonistic antibody to CD40 boosts the antitumor activity of adoptively transferred T cells in vivo.

Authors:  Chengwen Liu; Carol M Lewis; Yanyan Lou; Chunyu Xu; Weiyi Peng; Yan Yang; Alexander H Gelbard; Gregory Lizée; Dapeng Zhou; Willem W Overwijk; Patrick Hwu
Journal:  J Immunother       Date:  2012-04       Impact factor: 4.456

8.  Convergent and divergent effects of costimulatory molecules in conventional and regulatory CD4+ T cells.

Authors:  Ei Wakamatsu; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-31       Impact factor: 11.205

Review 9.  The Potential Role of Inhibitory Receptors in the Treatment of Psoriasis.

Authors:  Neha Shah; Sabina Sandigursky; Adam Mor
Journal:  Bull Hosp Jt Dis (2013)       Date:  2017-05

10.  Programmed Death-1 Inhibition of Phosphatidylinositol 3-Kinase/AKT/Mechanistic Target of Rapamycin Signaling Impairs Sarcoidosis CD4+ T Cell Proliferation.

Authors:  Lindsay J Celada; Joseph E Rotsinger; Anjuli Young; Guzel Shaginurova; Debresha Shelton; Charlene Hawkins; Wonder P Drake
Journal:  Am J Respir Cell Mol Biol       Date:  2017-01       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.